I

Immuneering Corporation (IMRX)

NGM – Real Time Price. Currency in USD

5.16

-0.02 (-0.39%)

Market open: May 13, 2026, 9:31 AM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Immuneering Corporation (IMRX)

NGM – Real Time Price. Currency in USD

5.16

-0.02 (-0.39%)

Market open: May 13, 2026, 9:31 AM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

317K

Cost of goods sold

-699K

-713K

-764K

-955K

Gross Profit

-699K

-713K

-764K

-638K

Operating expenses (excl. COGS)

-59M

-63M

-58M

-51M

Operating Income

-59M

-64M

-58M

-52M

Non-operating income, total

3M

5M

1M

Pretax income

-56M

-61M

-53M

-51M

Equity in earnings

0

Taxes

0

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-56M

-61M

-53M

-51M

Search stocks

Immuneering Corporation (IMRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Immuneering Corporation (IMRX)

Income Statement (Annual)